U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by Natixis Advisors LLC

Key Points

• Natixis Advisors LLC reduced its holdings in U.S. Physical Therapy shares by 35.2% in the first quarter, decreasing its ownership to approximately 17,712 shares valued at $1.28 million.
• U.S. Physical Therapy reported earnings of $0.81 per share, exceeding analysts' expectations of $0.71, with a revenue of $197.34 million for the quarter, a year-over-year increase of 18.0%.
• The company announced a quarterly dividend of $0.45 per share, resulting in an annualized dividend yield of 2.1%, to be paid out on September 12th.

Natixis Advisors LLC decreased its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 35.2% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 17,712 shares of the company's stock after selling 9,634 shares during the quarter. Natixis Advisors LLC owned about 0.12% of U.S. Physical Therapy worth $1,282,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of USPH. Point72 Asia Singapore Pte. Ltd. bought a new stake in U.S. Physical Therapy in the fourth quarter worth $39,000. Fifth Third Bancorp raised its position in U.S. Physical Therapy by 34.6% in the 1st quarter. Fifth Third Bancorp now owns 1,030 shares of the company's stock worth $75,000 after purchasing an additional 265 shares during the period. Lazard Asset Management LLC bought a new stake in U.S. Physical Therapy in the fourth quarter worth about $84,000. Aquatic Capital Management LLC lifted its stake in shares of U.S. Physical Therapy by 18.0% during the 4th quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock worth $115,000 after acquiring an additional 198 shares during the last quarter. Finally, First Horizon Advisors Inc. lifted its stake in shares of U.S. Physical Therapy by 35.0% during the 1st quarter. First Horizon Advisors Inc. now owns 1,929 shares of the company's stock worth $140,000 after acquiring an additional 500 shares during the last quarter.

Analyst Ratings Changes

USPH has been the subject of a number of research analyst reports. JMP Securities reissued a "market outperform" rating and set a $113.00 price target on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Barrington Research lifted their target price on U.S. Physical Therapy from $98.00 to $103.00 and gave the company an "outperform" rating in a research report on Friday, August 8th. Finally, Wall Street Zen raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $110.25.

U.S. Physical Therapy Stock Down 3.0%

NYSE USPH traded down $2.66 on Thursday, reaching $85.87. 54,333 shares of the stock traded hands, compared to its average volume of 143,859. U.S. Physical Therapy, Inc. has a 12 month low of $62.77 and a 12 month high of $101.19. The company has a fifty day moving average price of $77.19 and a 200-day moving average price of $77.09. The company has a market cap of $1.31 billion, a price-to-earnings ratio of 37.51, a PEG ratio of 4.40 and a beta of 1.45. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.17 and a current ratio of 1.18.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.71 by $0.10. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%. The business had revenue of $197.34 million for the quarter, compared to the consensus estimate of $190.24 million. During the same period last year, the business posted $0.73 EPS. The business's revenue was up 18.0% compared to the same quarter last year. As a group, research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 12th. Investors of record on Friday, August 22nd will be paid a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.1%. The ex-dividend date is Friday, August 22nd. U.S. Physical Therapy's payout ratio is 78.60%.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,792 shares of the business's stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $86.57, for a total transaction of $155,133.44. Following the sale, the chief operating officer owned 22,246 shares in the company, valued at approximately $1,925,836.22. The trade was a 7.45% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Nancy Ham sold 400 shares of the business's stock in a transaction dated Thursday, June 12th. The shares were sold at an average price of $78.01, for a total value of $31,204.00. Following the sale, the director owned 2,594 shares in the company, valued at approximately $202,357.94. The trade was a 13.36% decrease in their position. The disclosure for this sale can be found here. 2.00% of the stock is owned by insiders.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.